title: Pharmaceuticals and Medical Devices: FDA Oversight.
authors.forename: Melissa D
authors.initials: MD
authors.lastname: Berry
authors.forename: Robert S
authors.initials: RS
authors.lastname: White
mesh_terms: D014487:Centers for Medicare and Medicaid Services, U.S.; D003132:Commerce; D016494:Computer Security; D018795:Device Approval / Q000331:legislation & jurisprudence*; D055615:Electrical Equipment and Supplies; D004868:Equipment Failure; D004869:Equipment Safety; D004864:Equipment and Supplies / Q000009:adverse effects*; D005060:Europe; D005249:Fees and Charges / Q000331:legislation & jurisprudence; D005607:Fraud / Q000331:legislation & jurisprudence; D005819:Genetic Markers; D005820:Genetic Testing / Q000295:instrumentation; D023281:Genomics / Q000295:instrumentation; D033161:Government Regulation; D006297:Health Services Accessibility; D006801:Humans; D019221:Mandatory Reporting; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence; D018670:Monitoring, Ambulatory / Q000295:instrumentation; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D018907:Privacy / Q000331:legislation & jurisprudence; D057051:Product Recalls and Withdrawals / Q000331:legislation & jurisprudence; D028743:Professional Misconduct; D013526:Surgical Mesh / Q000009:adverse effects; D019737:Transplants; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence; D000071243:Zika Virus Infection / Q000175:diagnosis
chemical_list: D005819:Genetic Markers